Indications for Heart Valve Replacement by Age Group

I. Experience with Heart Valve Replacement in Pediatric Patients.- 1. The durability of the St. Jude Medical(R) valve in children.- 2. A seven-year experience with the St. Jude Medical(R) heart valve.- 3. St. Jude Medical(R) cardiac valve experience in infants and children.- 4. Thromboembolic complications in pediatric patients undergoing valve replacement with the St. Jude Medical(R) prosthesis.- 5. Long-term results of valvular replacement in pediatric patients.- 6. Performance of mechanical valves in pediatric patients.- I. Discussion.- II. Heart Valve Replacement in Adults (Age 65 and Younger).- 7. Prospective randomized study of the St. Jude Medical(R), Bjork-Shiley(R), and Starr-Edwards(R) 6120 valve prostheses in the mitral position.- 8. Nine years experience with 1287 Carpentier-Edwards(R) porcine bioprostheses.- 9. Primary tissue failure in porcine aortic and bovine pericardial bioprostheses.- 10. Midterm follow-up of the BioImplant(TM) (Liotta) heart valve.- 11. A comparison of St. Jude Medical(R) and Carpentier-Edwards(R) xenograft valves in the mitral position.- 12. Three-dimensional visualization of velocity fields downstream of the St. Jude Medical(R) aortic valve implanted in pigs.- 13. Quality of life after valve replacement with the St. Jude Medical BioImplant(TM) heart valve: a four-year study.- 14. Cinefluoroscopic follow up of the St. Jude Medical(R) valve in the aortic position.- 15. Thromboembolism in adults with St. Jude Medical(R) valves on ticlopidine and aspirin maintenance.- 16. Midterm follow-up of the St. Jude Medical(R) heart valve.- II. Discussion.- III. Valve Replacement in the Elderly (Age 66 and Older).- 17. Combined valve and coronary artery bypass procedures in septuagenarians and octogenarians: results in 119 patients.- 18. The Ionescu-Shiley(R) xenobioprosthesis as an aortic valve substitute in patients 66 years of age and older.- 19. Valve replacement in the elderly: operative risk and early postoperative results.- 20. Aortic valve replacement in patients 75 years and over.- 21. Durabilty and long-term results of aortic valve replacement in the elderly.- III. Discussion.- IV. Considerations in Heart Valve Replacement.- 22. Mechanical or tissue valves: Factors influencing differential therapy.- 23. Comparative analysis of mechanical and bioprosthetic valves following aortic valve replacement.- 24. Technical problems in aortic valve re-replacement.- 25. Hydrodynamics of cardiac valve prostheses: Is excellence necessary?.- 26. Surgical treatment of prosthetic valve endocarditis.- 27. Performance of four different types of mechanical and two bioprosthetic valves in the tricuspid position.- 28. Comparison of reoperation and complications in double valve (mitral and aortic) implants with mechanical or biological prostheses.- 29. Quality of life in patients with mechanical heart valves: Influence of anticoagulation therapy and valve noise.- 30. Valved conduits and conduit exchange: long-term follow-up.- IV. Discussion.- V. Long-Term Clinical Follow-Up.- 31. Seven-year experience and follow-up with St. Jude Medical(R) prostheses.- 32. Durability and low thrombogenicity of the St. Jude Medical(R) heart valve: long-term follow-up.- 33. Aortic and mitral valve replacement with the St. Jude Medical(R) prosthesis: a nine-year update report.- 34. Eight-year clinical experience with the St. Jude Medical(R) cardiac prosthetic valve.- 35. Heart valve replacement with the St. Jude Medical(R) valve prosthesis: long-term experience in 743 patients receiving valve implants in Switzerland.- V. Discussion.